Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TRACER is a specialized Clinical Research Organization (CRO) that provides molecular imaging services to accelerate drug development for pharmaceutical and biotech companies. Based in Groningen, Netherlands, the company specializes in radiolabeling various drug modalities—including small molecules, antibodies, and cell therapies—to enable PET and SPECT imaging in clinical trials. By utilizing microdosing strategies and advanced imaging techniques, TRACER allows developers to visualize drug distribution, target engagement, and pharmacokinetics directly in humans at an early stage. This 'imaging-first' approach helps de-risk clinical programs and provides essential data for dose selection and patient stratification. The company operates in close collaboration with the University Medical Center Groningen, leveraging world-class facilities for GMP tracer production and clinical execution. Their expertise supports a wide range of therapeutic areas, with a particular focus on oncology and inflammatory diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tracer Center of Expertise.